Fig. 3From: Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in WuhanComparison of the decline rate in IgG antibody titer among the 219 subjects with positive total antibodies at baseline and three consecutive serum samples. A Comparison of the decline rate between underlying diseases and no underlying diseases. B A total of 65 people in the underlying disease group were positive for antibodies at baseline and in three consecutive samples. Comparison of the following three groups: hypertension group, hypertension combined with other diseases group, and other underlying diseases group. **P < 0.01; ***P < 0.001; ns: no significanceBack to article page